The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”
Mozafar M, Kazemian S, Hoseini E, Mohammadi M, Alimoghadam R, Shafie M, Mayeli M, Initiative T. The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”. Clinical Parkinsonism & Related Disorders 2022, 8: 100177. PMID: 36590455, PMCID: PMC9798165, DOI: 10.1016/j.prdoa.2022.100177.Peer-Reviewed Original ResearchSpecific binding ratioUric acid levelsMDS-UPDRS III scoreIII scoreHealthy controlsMDS-UPDRSFollow-upGBA mutationsBaseline uric acid levelAcid levelsGlucocerebrosidase mutationsYears of follow-upH&Y stageParkinson's Progression Markers InitiativeMovement Disorder Society Unified Parkinson's Disease Rating ScaleSporadic PDBody mass indexParkinson's Disease Rating Scale IIIParkinson's diseaseBlood uric acid levelsUnified Parkinson's Disease Rating ScaleParkinson's Disease Rating ScaleDisease Rating ScaleBaseline characteristicsClinical characteristics
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply